Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Generation of Myeloid Cells in Cancer: The Spleen Matters
Chong Wu, Qiaomin Hua, Limin Zheng
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic
Amit Grover, Emilio Sanseviero, Elina Timosenko, et al.
Cancer Discovery (2021) Vol. 11, Iss. 11, pp. 2693-2706
Closed Access | Times Cited: 136
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Hao Lin, Chaxian Liu, An-Kang Hu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 62
Trained immunity in chronic inflammatory diseases and cancer
George Hajishengallis, Mihai G. Netea, Triantafyllos Chavakis
Nature reviews. Immunology (2025)
Closed Access | Times Cited: 4
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer
Ajeeth K. Pingili, Mehdi Chaib, Laura M. Sipe, et al.
Cell Reports (2021) Vol. 35, Iss. 12, pp. 109285-109285
Open Access | Times Cited: 76
Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
Huimin Tao, Mingyu Liu, Yuan Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 53
Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer
Marta Falcinelli, Gheed Alhity, S. Baron, et al.
Brain Behavior and Immunity (2023) Vol. 110, pp. 1-12
Open Access | Times Cited: 21
Glycolytic neutrophils accrued in the spleen compromise anti-tumour T cell immunity in breast cancer
Yu Wang, Muhan Xu, Jian Sun, et al.
Nature Metabolism (2023) Vol. 5, Iss. 8, pp. 1408-1422
Closed Access | Times Cited: 19
5-FU mediated depletion of myeloid suppressor cells enhances T-cell infiltration and anti-tumor response in immunotherapy–resistant lung tumor
Ambily Anna Mathew, Zahara Thaivalappil Zakkariya, Anusha Ashokan, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110129-110129
Closed Access | Times Cited: 17
Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development
Tomasz M. Grzywa, Magdalena Justyniarska, Dominika Nowis, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 870-870
Open Access | Times Cited: 35
PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
Mingyu Liu, Chong Wu, Shufeng Luo, et al.
The Journal of Experimental Medicine (2022) Vol. 219, Iss. 4
Open Access | Times Cited: 24
Targeting cGAS/STING signaling-mediated myeloid immune cell dysfunction in TIME
Vijay Kumar, Caitlin Bauer, John H. Stewart
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 16
ZBTB46 coordinates angiogenesis and immunity to control tumor outcome
Ashraf Ul Kabir, Carisa Zeng, Madhav Subramanian, et al.
Nature Immunology (2024) Vol. 25, Iss. 9, pp. 1546-1554
Closed Access | Times Cited: 5
Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis
Lea Monteran, Nour Ershaid, Idan Sabah, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 33
Polymersomes as a potential platform for cancer immunotherapy
Jari F. Scheerstra, Annelies C. Wauters, Jurjen Tel, et al.
Materials Today Advances (2021) Vol. 13, pp. 100203-100203
Open Access | Times Cited: 30
Who Knew? Dopamine Transporter Activity Is Critical in Innate and Adaptive Immune Responses
Adithya Gopinath, Phillip Mackie, Leah Phan, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 269-269
Open Access | Times Cited: 12
Myeloid-Derived Suppressor–Cell Dynamics Control Outcomes in the Metastatic Niche
Jesse Kreger, Evanthia T. Roussos Torres, Adam L. MacLean
Cancer Immunology Research (2023) Vol. 11, Iss. 5, pp. 614-628
Open Access | Times Cited: 12
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy
Annelies C. Wauters, Jari F. Scheerstra, Mandy M. T. van Leent, et al.
Nature Nanotechnology (2024) Vol. 19, Iss. 11, pp. 1735-1744
Open Access | Times Cited: 4
Enhancing antitumor immunity through chemotherapeutic-derived lipid nanoparticle-induced immunogenic cell death and CD40L/Flt3L mRNA-mediated dendritic cell activation
Xucheng Hou, Chang Wang, Yichen Zhong, et al.
Journal of Controlled Release (2025), pp. 113684-113684
Closed Access
Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors
Eva Reijmen, Sven de Mey, Wout de Mey, et al.
International Journal of Radiation Oncology*Biology*Physics (2021) Vol. 111, Iss. 1, pp. 272-283
Open Access | Times Cited: 26
An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model
Gheed Alhity, Fengwei Yang, Eduard Campillo-Funollet, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 24
Transforming growth f actor‐beta1 and m yeloid‐derived suppressor cells: A cancerous partnership
Slavko Mojsilović, Sonja S. Mojsilović, Sunčica Kapor, et al.
Developmental Dynamics (2021) Vol. 251, Iss. 1, pp. 85-104
Open Access | Times Cited: 22
Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model
Olga Trofimova, Ksenija Korotkaja, Dace Skrastiņa, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1247-1247
Open Access | Times Cited: 20
Nanotechnology‐Based Strategies to Evaluate and Counteract Cancer Metastasis and Neoangiogenesis
Özlem Şen, Melis Emanet, Gianni Ciofani
Advanced Healthcare Materials (2021) Vol. 10, Iss. 10
Open Access | Times Cited: 19
Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients
Richard Lewis, Stefan Habringer, Malte Kircher, et al.
EJNMMI Research (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 19
Red Blood Cells Protein Profile Is Modified in Breast Cancer Patients
Thais Pereira‐Veiga, Susana B. Bravo, Antonio Gómez‐Tato, et al.
Molecular & Cellular Proteomics (2022) Vol. 21, Iss. 12, pp. 100435-100435
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top